(2022) demonstrated Cerebrolysin's effects on Alzheimer's disease biomarkers in a randomized controlled trial, providing objective biological evidence for its neurotrophic activity (PMID: 36155516) Regulatory Validation: Approved for clinical use in over 40 countries for indications including stroke, traumatic brain injury, and dementia (though not FDA-approved in the United States) Dihexa: Preclinical Only, with Integrity Concerns Dihexa's evidence base is entirely preclinical and has faced significant scientific integrity challenges: Foundational Research: Wright et al
Specialized health tests directed by experts will reveal your genetic predispositions and food sensitivities
The redox-sensitive module of cyclophilin 20-3, 2-cysteine peroxiredoxin and cysteine synthase integrates sulfur metabolism and oxylipin signaling in the high light acclimation response
Due to its regenerative attributes, it has also been found to stimulate the proliferation of tendon cells and may be useful in regenerating neuronal cells
Responsible for a whole host of processes that support detoxification, digestion, immunity, and much more, this powerhouse often needs extra protection to keep functioning at full pace
